Publications
S Russell, A Wrobel, D Skvarc, B Kavanagh, M Ashton, O Dean, M Berk, A Turner
(2023), Vol. 26, pp. 61-69, The international journal of neuropsychopharmacology, England, C1
B Kavanagh, J O’Donohue, M Ashton, M Lotfaliany, M McCallum, A Wrobel, S Croce, M Berk, L Saunders, J Lai, L Berk
(2022), Vol. 13, Frontiers in Psychiatry, Switzerland, C1
A Systematic Review of Nutraceuticals for the Treatment of Bipolar Disorder
M Ashton, B Kavanagh, W Marx, M Berk, J Sarris, C Ng, M Hopwood, L Williams, O Dean
(2021), Vol. 66, pp. 262-273, Canadian Journal of Psychiatry, United States, C1
R Zazula, M Husain, M Mohebbi, A Walker, I Chaudhry, A Khoso, M Ashton, B Agustini, N Husain, J Deakin, A Young, M Berk, B Kanchanatawan, C Ng, M Maes, L Berk, A Singh, G Malhi, O Dean
(2021), Vol. 55, pp. 784-798, Australian and New Zealand Journal of Psychiatry, England, C1
B Kavanagh, M Ashton, S Cowdery, O Dean, A Turner, M Berk, S Gwini, S Brennan-Olsen, H Koivumaa-Honkanen, A Chanen, L Williams
(2021), Vol. 279, pp. 711-721, Journal of affective disorders, Amsterdam, The Netherlands, C1
A Turner, A Baker, O Dean, A Walker, S Dodd, S Cotton, J Scott, B Kavanagh, M Ashton, E Brown, J McGrath, M Berk
(2021), Vol. 66, pp. 354-366, Canadian Journal of Psychiatry, United States, C1
J Sarris, W Marx, M Ashton, C Ng, N Galvao-Coelho, Z Ayati, Z Zhang, S Kasper, A Ravindran, B Harvey, A Lopresti, D Mischoulon, J Amsterdam, L Yatham, M Berk
(2021), Vol. 66, pp. 849-862, Canadian Journal of Psychiatry, United States, C1
W Marx, D Skvarc, M Mohebbi, A Walker, A Meehan, A Turner, A Baker, S Dodd, S Cotton, J Scott, B Kavanagh, M Ashton, E Brown, J McGrath, M Berk, O Dean
(2021), Vol. 12, Frontiers in Psychiatry, Switzerland, C1
C Bortolasci, A Turner, M Mohebbi, Z Liu, M Ashton, L Gray, W Marx, A Walker, G Kowalski, F Jacka, M Berk, O Dean, K Walder
(2021), Vol. 142, pp. 376-383, Journal of Psychiatric Research, England, C1
K Hasebe, M Mohebbi, L Gray, A Walker, C Bortolasci, A Turner, M Berk, K Walder, M Maes, B Kanchanatawan, M Ashton, L Berk, C Ng, G Malhi, A Singh, O Dean
(2021), Vol. 34, Acta Neuropsychiatrica, England, C1
Bianca Kavanagh, Lana Williams, Michael Berk, Alyna Turner, Henry Jackson, Mohammadreza Mohebbi, Buranee Kanchanatawan, Melanie Ashton, Chee Ng, Michael Maes, Lesley Berk, Gin Malhi, Nathan Dowling, Ajeet Singh, Olivia Dean
(2020), Vol. 42, pp. 14-21, Brazilian journal of psychiatry, Sao Paulo, Brazil, C1
M Ashton, O Dean, W Marx, M Mohebbi, M Berk, G Malhi, C Ng, S Cotton, S Dodd, J Sarris, M Hopwood, K Faye-Chauhan, Y Kim, S Dash, F Jacka, N Shivappa, J Hebert, A Turner
(2020), Vol. 54, pp. 159-172, Australian and New Zealand journal of psychiatry, London, Eng., C1
M Ashton, M Mohebbi, A Turner, W Marx, M Berk, G Malhi, C Ng, S Cotton, S Dodd, J Sarris, M Hopwood, B Stubbs, O Dean
(2020), Vol. 65, pp. 306-318, Canadian journal of psychiatry, London, Eng., C1
Wolfgang Marx, Andrew Scholey, Joseph Firth, Nathan D’Cunha, Melissa Lane, Meghan Hockey, Melanie Ashton, John Cryan, A O'Neil, Nenad Naumovski, Michael Berk, Olivia Dean, Felice Jacka
(2020), Vol. 118, pp. 472-484, Neuroscience & Biobehavioral Reviews, Amsterdam, The Netherlands, C1
Melanie Ashton, Michael Berk, Chee Ng, Malcolm Hopwood, Seetal Dodd, Alyna Turner, Ellie Brown, Felice Jacka, Susan Cotton, Jon-Paul Khoo, Mary Chatterton, Bianca Kavanagh, Sarah Nadjidai, Samantha Lo Monaco, Brian Harvey, Jerome Sarris, Gin Malhi, Nathan Dowling, Olivia Dean
(2019), Vol. 41, pp. 245-253, Brazilian journal of psychiatry, Sao Paulo, Brazil, C1
M Ashton, O Dean, A Walker, C Bortolasci, C Ng, M Hopwood, B Harvey, M Möller, J McGrath, W Marx, A Turner, S Dodd, J Scott, J Khoo, K Walder, J Sarris, M Berk
(2019), Vol. 10, Frontiers in Psychiatry, Switzerland, C1
Alyna Turner, John McGrath, Olivia Dean, Seetal Dodd, Andrea Baker, Susan Cotton, James Scott, Bianca Kavanagh, Melanie Ashton, Adam Walker, Ellie Brown, Michael Berk
(2019), Vol. 17, pp. 297-307, Clinical psychopharmacology and neuroscience, Seoul, South Korea, C1
M Ashton, M Berk, C Ng, M Hopwood, B Kavanagh, L Williams, J Sarris, O Dean
(2019), Vol. 9, BMJ Open, England, C1
B Kavanagh, S Brennan-Olsen, A Turner, O Dean, M Berk, M Ashton, H Koivumaa-Honkanen, L Williams
(2019), Vol. 9, BMJ Open, England, C1
Mitochondrial agents for bipolar disorder
C Pereira, V Chavarria, J Vian, M Ashton, M Berk, W Marx, O Dean
(2018), Vol. 21, pp. 550-569, International Journal of Neuropsychopharmacology, England, C1
Beyond the therapeutic shackles of the monoamines: new mechanisms in bipolar disorder biology
J Data-Franco, A Singh, D Popovic, M Ashton, M Berk, E Vieta, M Figueira, O Dean
(2017), Vol. 72, pp. 73-86, Progress in neuro-psychopharmacology & biological psychiatry, Amsterdam, The Netherlands, C1
Adjunctive minocycline treatment for major depressive disorder: A proof of concept trial
O Dean, B Kanchanatawan, M Ashton, M Mohebbi, C Ng, M Maes, L Berk, A Sughondhabirom, S Tangwongchai, A Singh, H McKenzie, D Smith, G Malhi, N Dowling, M Berk
(2017), Vol. 51, pp. 829-840, Australian and New Zealand Journal of Psychiatry, England, C1
Staging in bipolar disorder: from theoretical framework to clinical utility
M Berk, R Post, A Ratheesh, E Gliddon, A Singh, E Vieta, A Carvalho, M Ashton, L Berk, S Cotton, P McGorry, B Fernandes, L Yatham, S Dodd
(2017), Vol. 16, pp. 236-244, World psychiatry, Chichester, Eng., C1
R Menon, L Cribb, J Murphy, M Ashton, G Oliver, N Dowling, A Turner, O Dean, M Berk, C Ng, J Sarris
(2017), Vol. 4, pp. 109-114, Advances in integrative medicine, Amsterdam, The Netherlands, C1
O Dean, O Dean, M Maes, M Maes, M Ashton, M Ashton, L Berk, L Berk, B Kanchanatawan, B Kanchanatawan, A Sughondhabirom, A Sughondhabirom, S Tangwongchai, S Tangwongchai, C Ng, C Ng, N Dowling, N Dowling, G Malhi, G Malhi, M Berk, M Berk
(2014), Vol. 12, pp. 180-188, Clinical psychopharmacology and neuroscience, Seoul, Korea, C1
Funded Projects at Deakin
Industry and Other Funding
The efficacy of adjunctive Garcinia mangostana linn (mangosteen) pericarp for bipolar depression: A 24-week double-blind, randomised, placebo controlled trial
A/Prof Olivia Dean, Dr Melanie Ashton
Australasian Society for Bipolar and Depressive Disorders Ltd
- 2017: $4,250
- 2016: $30,000
The efficacy of adjunctive Garcinia mangostana linn (mangosteen) pericarp for bipolar depression: A 24-week double-blind, randomised, placebo controlled trial
A/Prof Olivia Dean, Prof Michael Berk, Dr Melanie Ashton
Australian Rotary Health - Ian Parker Bipolar Fund Scholarship
- 2019: $15,750
- 2018: $17,000
- 2017: $13,136
- 2016: $3,863
Supervisions
No completed student supervisions to report